Kestra Medical Technologies (KMTS) Change in Receivables (2024 - 2026)
Kestra Medical Technologies (KMTS) has disclosed Change in Receivables for 3 consecutive years, with $2.7 million as the latest value for Q1 2026.
- Quarterly Change in Receivables fell 20.42% to $2.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.1 million through Jan 2026, down 20.3% year-over-year, with the annual reading at $8.8 million for FY2025, 251.36% up from the prior year.
- Change in Receivables for Q1 2026 was $2.7 million at Kestra Medical Technologies, up from $1.7 million in the prior quarter.
- The five-year high for Change in Receivables was $3.3 million in Q1 2025, with the low at $963000.0 in Q2 2025.
- Average Change in Receivables over 3 years is $2.0 million, with a median of $1.7 million recorded in 2025.
- Peak annual rise in Change in Receivables hit 7.91% in 2025, while the deepest fall reached 38.51% in 2025.
- Over 3 years, Change in Receivables stood at $1.6 million in 2024, then rose by 7.91% to $1.7 million in 2025, then skyrocketed by 56.07% to $2.7 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods came in at $2.7 million, $1.7 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.